Aliaxin® FL Lips

Description

Aliaxin FL Lips

Aliaxin® FL Lips is a filler to increase the volume of the lips.

The active substance is cross-linked hyaluronic acid.

It allows restoring a slight volume and correcting small asymmetries of the face while keeping a natural appearance.

The product is injected directly into the tissue to increase the intracutaneous volume.

The special structure of the gel implant guarantees excellent diffusion in the injected area.

Treated areas

• Lips

Composition by Aliaxin FL Lips

• Crosslinked hyaluronic acid: 25 mg/g
• Phosphate buffer, Water for solutions for injections: 1 g

The box contains:

• 2 syringes of cross-linked hyaluronic acid of 1 ml
• 4 sterile needles (30G x 13mm)
• 4 adhesive labels
• Label CE

Contraindications

• Pregnant or breastfeeding woman
• People under the age of 18
• Patients are known to demonstrate hypersensitivity to hyaluronic acid.
• Patients who tend to develop hypertrophic scars.
• Immediately before or after laser therapy, chemical peeling or dermabrasion.
• Areas with skin inflammation or signs of infection.

Dosage and administration

The volumetric gradation printed on the syringe has an indicative value. It is left to the discretion of the doctor to choose the dosage to be used for each case.
The intervals at which treatment must be repeated depending on various factors in the patient’s physiology (skin type, individual metabolism, anatomy, age) and lifestyle. Another element to be considered relates to the implantation techniques used.

The areas to be treated must be identified and evaluated, considering the criteria relating to the lines and symmetries to be followed.
A local anaesthetic can be used for a lip treatment to ensure the necessary comfort to the patient.
The doctor must inform the patient in advance of the modalities of the intervention. The potential adverse reactions are its nature, the warnings, precaution,s and possible individual results. The expected duration of the implant and the possibility of additional intervention for the maintenance and/or the definition in detail of the result obtained. The intervention area should be cleaned with an antiseptic solution before proceeding with the implant.

It is advisable to repeat the treatment periodically, every 6-12 months, to maintain the results obtained.

Qualified practitioners must inject this product.

Manufacturer: IBSA
Strength: 25mg/ml
Pack Size: 2-1ml prefilled syringe